Finance

Beta
Lists
6CQ:FRA
Cresco Labs Inc
€0.76
-3.32%
(-0.026) 1D
Jun 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6CQ...
Open
€0.76
High
€0.76
Low
€0.72
Mkt. cap
427.18M
Avg. vol.
443.00
Volume
0.00
52-wk high
€1.90
52-wk low
€0.36
No. of employees
3K
Open
€0.76
High
€0.76
Low
€0.72
Mkt. cap
427.18M
Avg. vol.
443.00
Volume
0.00
52-wk high
€1.90
52-wk low
€0.36
No. of employees
3K
News stories
From sources across the web
Profile
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use. The company's stock trades on the Canadian Securities Exchange under the ticker symbol CL, and in over-the-counter markets in the United States with the ticker symbol CRLBF. Wikipedia
About Cresco Labs Inc
CEO-
Employees2.9K
Founded2013
HeadquartersChicago, Illinois, United States
SectorPharmaceutical industry
Websitecrescolabs.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
166.12M
164.91M
161.55M
151.32M
Cost of goods sold
80.37M
85.55M
78.23M
75.88M
Cost of revenue
80.37M
85.55M
78.23M
75.88M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.00M
53.53M
60.43M
59.36M
Operating expense
60.34M
59.17M
65.40M
64.28M
Total operating expenses
140.71M
144.72M
143.63M
140.15M
Operating income
25.41M
20.19M
17.92M
11.17M
Other non operating income
442.00K
4.21M
4.23M
1.34M
EBT including unusual items
2.74M
-10.10M
-87.15M
-2.79M
EBT excluding unusual items
12.68M
10.06M
7.62M
-2.75M
Income tax expense
16.64M
11.87M
1.80M
14.22M
Effective tax rate
606.30%
-117.48%
-2.07%
-508.95%
Other operating expenses
-
-
-
-
Net income
-16.33M
-17.05M
-87.59M
-13.07M
Net profit margin
-9.83%
-10.34%
-54.22%
-8.64%
Earnings per share
-0.02
0.01
-0.03
-0.04
Interest and investment income
905.00K
699.00K
1.30M
407.00K
Interest expense
-13.47M
-15.27M
-15.63M
-15.33M
Net interest expenses
-12.56M
-14.57M
-14.33M
-14.93M
Depreciation and amortization charges
4.42M
5.64M
4.97M
4.92M
EBITDA
37.60M
33.05M
28.68M
23.39M
Gain or loss from assets sale
658.00K
-2.60M
352.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer